Use of ketorolac in sickle-cell disease and vaso-occlusive crisis-Reference-Cited by-同舟云学术

Use of ketorolac in sickle-cell disease and vaso-occlusive crisis

Published:1991-09 Issue:8767 Volume:338 Page:641-642
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Goodman Elizabeth

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. Acute chest syndrome in pediatric patients with sickle cell disease: a retrospective analysis of 100 hospitalized patients;Sprinkle;Am J Pediatr Hematol Oncol,1986

2. Acute lung syndrome during painful sickle cell crisis: relation to site of pain and narcotic requirement;Palmer;Blood,1983

3. Acute chest syndrome in sickle cell disease: etiology and clinical correlates;Ponez;J Pediatr,1985

4. Ketorolac: an injectable NSAID;DiPalma;Am Fam Physician,1991

5. Comparison of intramuscular ketorolac and morphine in pain control after laparotomy;Powell;Anaesthesia,1990

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of glutamic acid/polyvinyl alcohol based hydrogels for controlled drug release: In-vitro characterization and in-vivo evaluation;Journal of Drug Delivery Science and Technology;2022-09

2. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease;Pediatric Drugs;2017-08-29

3. Pharmacokinetics of ketorolac loaded to polyethylcyanoacrylate nanoparticles using UPLC MS/MS for its determination in rats;International Journal of Pharmaceutics;2010-09

4. Sickle cell disease—when opioids and physicians fail;General Hospital Psychiatry;2002-11

5. Treatment of Sickle Cell Pain;Pharmacotherapy;2002-04